
GSR Launches Enhanced Systematic OTC Platform, Expanding FX Capabilities and Asset Coverage
London, United Kingdom, June 25th, 2025, Chainwire
GSR, crypto's capital markets partner, today announced a major upgrade to its systematic over-the-counter (OTC) trading platform, expanding foreign exchange (FX) capabilities, improving execution quality, and broadening access to hundreds of digital assets.
The upgraded platform introduces both a new user interface (UI) and an enhanced API, giving clients flexible access to GSR's liquidity across more than 200 digital assets and 25 fiat currencies. This development reflects GSR's mission to help founders and institutions scale with confidence by providing institutional-grade liquidity solutions that meet the demands of a rapidly evolving market.
This upgrade further strengthens GSR's position as the bridge between traditional finance and cryptocurrency markets.
'This is a meaningful step forward in GSR's commitment to making digital asset trading infrastructure truly institutional,' said Jakob Palmstierna, President, GSR. 'With systematic OTC accessible through both our API and UI, we're enabling clients to engage with markets faster, more transparently, and with greater precision.'
Key highlights of the upgrade include:
Tighter, More Competitive Pricing:
The upgraded platform delivers improved pricing across major crypto pairs, leveraging proprietary algorithms and liquidity from GSR's global network of counterparties.
Institutional FX Integration:
Clients now benefit from seamless crypto-to-fiat and fiat-to-fiat execution across more than 25 fiat currencies, with pricing aligned with traditional FX prime brokerage standards. Support includes large trade sizes, up to $100 million per trade or the equivalent in other currencies, with direct access to tier-one FX liquidity.
Unmatched Breadth of Assets:
Clients in approved jurisdictions can access hundreds of digital assets, including altcoins, stablecoins, and emerging tokens, across all trading combinations through both GSR's precision-built UI and robust API. This seamless access to over 200 assets makes it one of the most comprehensive OTC offerings in the industry.
'This addition to our product offering reinforces our commitment to delivering institutional-grade trading solutions across the digital asset spectrum,' said Kunal Mehta, Head of Trading, GSR. 'By combining deep liquidity, best-in-class FX capabilities, and extensive asset coverage, we're enabling our clients to trade smarter, faster, and more globally.'
With over a decade of specialized expertise in digital assets, GSR delivers more than just execution; we offer deep market insight, strategic guidance, and tailored infrastructure to support growth at every stage.
About GSR
GSR is crypto's capital markets partner, delivering market making services, institutional-grade OTC trading, and venture backing to founders and institutions. With more than a decade of experience, we provide strategic guidance, market intelligence, and access to a global network to help teams scale. Users can visit www.gsr.io for more information, including the General Terms of Business of Business, relevant disclosures, and GSR's trading terms.
Contact
GSR

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Miami Herald
16 hours ago
- Miami Herald
New to The Street Announces the Broadcast of Show Number 675 This Saturday at 6:30 PM EST on Bloomberg Television Featuring: FLOKI, BioVie (NASDAQ: BIVI), Arrive AI ($ARAI), Health In Tech (NASDAQ HIT), and Commercialville T.V.
Show Number 675 is sponsored programming by Ainos (NASDAQ: AIMD), Arrive AI ($ARAI), Acurx Pharmaceuticals (NASDAQ: ACXP), Sustainable Green Team (OTC: SGTM) and Commercialville T.V. commercials NEW YORK CITY, NEW YORK / ACCESS Newswire / June 27, 2025 / New to The Street proudly announces the broadcast of Show Number 675, airing this Saturday at 6:30 PM EST on Bloomberg Television. Show Number 675 marks a major milestone for the nationally syndicated program known for its in-depth interviews and business features spanning emerging technologies, biotech, fintech, and media. Show Number 675 will feature the following companies: FLOKI - A leading Web3 utility and metaverse token with a growing ecosystem across blockchain, education, and decentralized Inc. (NASDAQ:BIVI) - A clinical-stage biotech company advancing therapeutic solutions for Alzheimer's and advanced liver AI ($ARAI) - A next-generation logistics platform utilizing AI to streamline smart deliveries and mail In Tech - A digital health platform transforming underwriting and broker tools for next-gen insurance T.V. -CommercialVille T.V. is an innovative, zip‑code‑targeted, video‑based search engine designed specifically for local advertising. Using its patented technology, it delivers location‑relevant video ads directly to users based on entered zip codes and keywords. Show Number 675 is sponsored programming brought to audiences by: Ainos, Inc. (NASDAQ:AIMD) - Focused on developing innovative point-of-care diagnostics and therapeutic monitoring AI ($ARAI) - Disrupting traditional logistics with AI-powered predictive Pharmaceuticals, Inc. (NASDAQ:ACXP) - Developing a new class of antibiotics addressing multidrug-resistant Gram-positive T.V. - Blending entertainment and e-commerce into a measurable media platform. Vince Caruso, CEO and C0 Founder of New to The Street, commented: Show Number 675 will also stream on the New to The Street YouTube channel (2.9M+ subscribers), and be shared across social media and digital distribution networks globally. For media, sponsorship, or interview inquiries related to Show Number 675:Monica BrennanMonica@ About New to The StreetSince 2009, New to The Street has produced over 675 episodes, airing weekly on Bloomberg Television and Fox Business as sponsored programming. Known for combining linear TV with digital media, social amplification, and billboard coverage, New to The Street provides a powerful media platform for public and private companies looking to elevate their visibility. SOURCE: New To The Street

Associated Press
21 hours ago
- Associated Press
BioNxt Solutions Announces Revocation of Management Cease Trade Order
VANCOUVER, BC / ACCESS Newswire / June 27, 2025 / BioNxt Solutions Inc. ('BioNxt' or the 'Company') (CSE:BNXT)(OTC PINK:BNXTF)(FSE:BXT), is pleased to announce that effective immediately, the British Columbia Securities Commission has revoked the temporary management cease trade order ('MCTO') it had previously granted to the Company on May 1, 2025 under National Policy 12-203 Management Cease Trade Orders, as the Company successfully completed the filing of its annual audited financial statements, management's discussion and analysis, and related certifications for the year ended December 31, 2024 (collectively, the 'Annual Filings') on June 26, 2025. The revocation of the MCTO means members of management are no longer prevented from trading the Company's securities. All of the Annual Filings are available under the Company's profile on SEDAR+ at About BioNxt Solutions Inc. BioNxt Solutions Inc. is a bioscience innovator focused on next‐generation drug delivery technologies, diagnostic screening systems, and active pharmaceutical ingredient development. The Company's proprietary platforms-Sublingual (Thin‐Film), Transdermal (Skin Patch), and Oral (Enteric‐Coated Tablets)-target key therapeutic areas, including autoimmune diseases, neurological disorders, and longevity. With research and development operations in North America and Europe, BioNxt is advancing regulatory approvals and commercialization efforts, primarily focused on European markets. BioNxt is committed to improving healthcare by delivering precise, patient‐centric solutions that enhance treatment outcomes worldwide. BioNxt is listed on the Canadian Securities Exchange: BNXT, OTC Markets: BNXTF and trades in Germany under WKN: A3D1K3. To learn more about BioNxt, please visit Investor Relations & Media Contact Hugh Rogers, Co‐Founder, CEO and Director Email: [email protected] Phone: +1 778.598.2698 Web: LinkedIn: Instagram: Cautionary Statement Regarding 'Forward‐Looking' Information This news release includes certain statements that may be deemed 'forward-looking statements'. All statements in this release, other than statements of historical facts, that address events or developments that the Company expects to occur, are forward-looking statements. Forward-looking statements are statements that are not historical facts and are generally, but not always, identified by the words 'expects', 'plans', 'anticipates', 'believes', 'intends', 'estimates', 'projects', 'potential' and similar expressions, or that events or conditions 'will', 'would', 'may', 'could' or 'should' occur. Forward-looking information in this news release includes the anticipated filing date of the Annual Filings. Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results may differ materially from those in the forward-looking statements. Factors that could cause the actual results to differ materially from those in forward-looking statements include regulatory actions, market prices, and continued availability of capital and financing, and general economic, market or business conditions. Investors are cautioned that any such statements are not guarantees of future performance and actual results or developments may differ materially from those projected in the forward-looking statements. Forward-looking statements are based on the beliefs, estimates and opinions of the Company's management on the date the statements are made. Except as required by applicable securities laws, the Company undertakes no obligation to update these forward-looking statements in the event that management's beliefs, estimates or opinions, or other factors, should change. SOURCE: BioNxt Solutions Inc. press release


USA Today
a day ago
- USA Today
New to The Street Announces the Broadcast of Show Number 675 This Saturday at 6:30 PM EST on Bloomberg Television Featuring: FLOKI, BioVie (NASDAQ: BIVI), Arrive AI ($ARAI), Health In Tech (NASDAQ HIT), and Commercialville T.V.
new to the street Show Number 675 is sponsored programming by Ainos (NASDAQ: AIMD), Arrive AI ($ARAI), Acurx Pharmaceuticals (NASDAQ: ACXP), Sustainable Green Team (OTC: SGTM) and Commercialville T.V. commercials New to The Street proudly announces the broadcast of Show Number 675, airing this Saturday at 6:30 PM EST on Bloomberg Television. Show Number 675 marks a major milestone for the nationally syndicated program known for its in-depth interviews and business features spanning emerging technologies, biotech, fintech, and media. Show Number 675 will feature the following companies: FLOKI – A leading Web3 utility and metaverse token with a growing ecosystem across blockchain, education, and decentralized finance. BioVie Inc. (NASDAQ:BIVI) – A clinical-stage biotech company advancing therapeutic solutions for Alzheimer's and advanced liver disease. Arrive AI ($ARAI) – A next-generation logistics platform utilizing AI to streamline smart deliveries and mail infrastructure. Health In Tech – A digital health platform transforming underwriting and broker tools for next-gen insurance services. Commercialville T.V. –CommercialVille T.V. is an innovative, zip‑code‑targeted, video‑based search engine designed specifically for local advertising. Using its patented technology, it delivers location‑relevant video ads directly to users based on entered zip codes and keywords. Show Number 675 is sponsored programming brought to audiences by: Ainos, Inc. (NASDAQ:AIMD) – Focused on developing innovative point-of-care diagnostics and therapeutic monitoring technologies. Arrive AI ($ARAI) – Disrupting traditional logistics with AI-powered predictive infrastructure. Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) – Developing a new class of antibiotics addressing multidrug-resistant Gram-positive infections. Commercialville T.V. – Blending entertainment and e-commerce into a measurable media platform. Vince Caruso, CEO and C0 Founder of New to The Street, commented: 'We're excited to bring audiences Show Number 675, showcasing disruptive companies across multiple sectors. As we expand our platform on Bloomberg, Fox Business, and digital syndication, we remain committed to helping innovators scale their story and visibility.' Show Number 675 will also stream on the New to The Street YouTube channel (2.9M+ subscribers), and be shared across social media and digital distribution networks globally. For media, sponsorship, or interview inquiries related to Show Number 675: Monica Brennan Monica@ About New to The Street Since 2009, New to The Street has produced over 675 episodes, airing weekly on Bloomberg Television and Fox Business as sponsored programming. Known for combining linear TV with digital media, social amplification, and billboard coverage, New to The Street provides a powerful media platform for public and private companies looking to elevate their visibility. SOURCE: New To The Street View the original press release on ACCESS Newswire